Alpa Laboratories Ltd
₹61.69
-1.49%
Delayed · cached 15 min
Fair value analysis
ALPA
Alpa Laboratories Ltd
₹62.62
Close used for this calculation
₹53.66Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
46/100
Quality radar
Consensus fair value
₹53.66
Near FV▼ -14.3% against the close used
Model range ₹14.50 – ₹254.54
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹14.50Fair value₹53.66Bull₹254.54
FairClose
52-week traded range
52W low ₹46.4652W high ₹95.43
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Alpa Laboratories Ltd closed at ₹62.62, 16.7% above the consensus fair value of ₹53.66 drawn from 9 valuation models.
Financial DNA score 46/100 — Average. P/E of 32.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹48.29
-22.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=6%, r=10%, tg=3%, n=10yr
Graham Number
₹62.40
-0.4%
√(22.5 × EPS × BVPS)
EPS=7.13, BVPS=24.27 · outside Graham range (P/E 32, P/B 2.6) — asset-light, treat as a rough floor
Graham Formula
₹135.72
+116.7%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=6%, FD=7%
P/E Fair Value
₹254.54
+306.5%
EPS × 35.7x (sector P/E)
EPS=7.13, Sector P/E=35.7x
Peter Lynch (PEG)
₹42.78
-31.7%
EPS × Growth% (PEG = 1 is fair)
EPS=7.13, g=6%
EV/EBITDA
₹29.86
-52.3%
(EBITDA × 13x − Net Debt) ÷ Shares
EBITDA=50M
Book Value (P/B)
₹14.50
-76.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=24.27, ROE=8.4%, g=6%, r=10%
Reverse DCF
₹62.62
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -4.1% | Historical: 6%
Margin of Safety
₹93.93
+50.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=125.24, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.